Looking for a Zyprexa attorney in District of Columbia? Get in touch with one of our Zyprexa attorneys in District of Columbia now.
Home : Unsafe Drugs : Zyprexa : News Articles
Zyprexa - News Articles
-
May 1, 2008
Psychiatric Services (subscription) -
OBJECTIVE: This study examined changes in prescribing patterns of antipsychotic medications to treat schizophrenia. METHODS: Pharmacy records for patients ... -
May 8, 2008
CNNMoney.com (press release) -
In the trials, both asenapine and the active-control drug olanzapine* produced greater mean reductions in YMRS total scores versus placebo after three weeks ... -
Apr 20, 2008
PR-USA.net (press release), Bulgaria -
Senior study author Dominique Hermier said, “Based on these findings we concluded that male rats treated with olanzapine (Zyprexa) experienced an early ... -
May 11, 2008
TheNewsTribune.com, WA -
They’re sold under the names Zyprexa, Geodon, Risperdal, Abilify, Seroquel, Clozaril and Invega. The drugs belong to a relatively new class of anti-psychotics called “atypical.” The older class of anti-psychotics has been on the market for decades. So far, ... -
Apr 30, 2008
Indianapolis Business Journal, IN -
Lawsuits claiming that Indianapolis-based Eli Lilly and Co. hid from shareholders information about marketing and health risks of its Zyprexa drug were dismissed today by a judge in Brooklyn, N.Y., according to Bloomberg. The suits, which hadn’t gone to trial, ... -
Apr 30, 2008
Law.com (subscription), CA -
Zyprexa was approved by the Food and Drug Administration for the treatment of schizophrenia in 1996. The FDA extended its approval to certain bipolar-disorder uses in 2000 and for additional bipolar uses in 2004. The drug became one of the company's ... -
Wednesday, May 14, 2008
Indianapolis Business Journal, IN -
The company survived by growing sales of its antipsychotic medicine Zyprexa into an even bigger blockbuster. But a few missteps, legal and regulatory hurdles, and a general downturn in the pharmaceutical industry have caused Lilly to stagnate on Wall Street. ... -
Apr 21, 2008
Wall Street Journal -
By MIKE BARRIS Eli Lilly & Co.'s first-quarter net income more than doubled on a tax gain and year-earlier charges, as strong sales of its popular Cymbalta ... -
Apr 21, 2008
The Associated Press -
INDIANAPOLIS (AP) — Drug maker Eli Lilly and Co. said strong sales for Cymbalta and Cialis helped double its first-quarter profit, but results missed Wall Street expectations. Company shares fell 3 percent, or $1.57, to $50.50 in early trading Monday. The Indianapolis-based ... -
Apr 21, 2008
Bloomberg -
By Elizabeth Lopatto April 21 (Bloomberg) -- Eli Lilly & Co., the world's biggest maker of psychiatric drugs, missed analysts' earnings estimates after ...
-
Apr 21, 2008
Forbes, NY -
AP 04.21.08, 10:35 AM ET TRENTON, NJ (AP) - The drugmaker Merck & Co. on Monday reported that its profit almost doubled in the first quarter due to a $1.4 billion distribution from a partner drug company. Its sales were slightly higher than a year ago. INDIANAPOLIS ... -
Apr 21, 2008
MarketWatch -
By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- Eli Lilly & Co. reported Monday that its first-quarter profit more than doubled, due primarily to a major accounting gain taken this year for the resolution of a tax matter and also reflecting hefty ... -
Apr 21, 2008
MarketWatch -
By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- Drug stocks moved lower Monday as shares of Eli Lilly & Co. slipped on a mixed first-quarter earnings report. ... -
Apr 21, 2008
TheStreet.com -
Eli LillyLLY fell shy of first-quarter expectations on Monday, giving up nearly 5% in morning trading. The Indianapolis, Ind.-based pharmaceutical company benefitted from foreign exchange rates, a tax-audit resolution and strong sales in some of its drug arsenal, but also ... -
Apr 21, 2008
Forbes, NY -
Even though Eli Lilly reported strong sales of two of its drugs, it missed Wall Street's forecasts Monday, sending its shares lower. Miller Tabak analyst Les Funtleyder said that Lilly has the same issues as its pharmaceutical peers: it's ... -
Apr 22, 2008
Motley Fool -
By Brian Lawler April 22, 2008 It's always tough to complain anytime a large-cap drugmaker boosts its revenue 14% in a quarter. So I'll be hard-pressed to ... -
May 9, 2008
Hilton Head Island Packet, SC -
(A) Year 1996 FDA approves Zyprexa for schizophrenia (at first,later on for mania) which is only about 1% and 3% of the population to lessen delusional hallucinations of schizophrenia. The drug goes on to become Lilly's top seller at $4.2 billion a year.How does ... -
May 9, 2008
indiainteracts.com, India -
Lilly"s credibility over their continuous PR on how they are going to pay out $1.2 billion in Zyprexa damages.Many claimants are being stonewalled! Eli Lilly makes billions on diabetes treatment and also gets $4.2 billion ... -
Apr 18, 2008
CNNMoney.com -
NEW YORK (Associated Press) - Eli Lilly & Co. reports earnings for the first quarter on Monday. The following is a summary of key developments and analyst ... -
Jan 19, 2008
Vancouver Sun, Canada -
At issue in the Novopharm lawsuit is the right for either company to have its version of the schizophrenia drug olanzapine added to a list of drugs paid for by the B.C. government through Pharmacare, a program that assists B.C. residents with the cost of drugs and medical ...
Looking for a Zyprexa attorney in District of Columbia? Get in touch with one of our Zyprexa attorneys in District of Columbia now.
Pages: Previous ... 3 4 5 6 7 8 9 10 11 12 13 ... Next
These articles are related to: Zyprexa Claim, Zyprexa Lawsuit, Zyprexa Law Suit, Zyprexa Law Firm, Zyprexa Lawyer, Zyprexa Attorney, Zyprexa Side Effects Symptoms, Zyprexa Trial, Zyprexa Verdict, Zyprexa News, Zyprexa Information, Zyprexa Recall Lawyers, Zyprexa Warning, Zyprexa Class Action, Zyprexa Prescription Drug, Zyprexa Medication, Zyprexa Drugs, Olanzapine Claim, Olanzapine Lawsuit, Olanzapine Law Suit, Olanzapine Law Firm, Olanzapine Lawyer, Olanzapine Attorney, Olanzapine Side Effects Symptoms, Olanzapine Trial, Olanzapine Verdict, Olanzapine News, Olanzapine Information, Olanzapine Recall Lawyers, Olanzapine Warning, Olanzapine Class Action, Olanzapine Prescription Drug, Olanzapine Medication, Olanzapine Drugs, Zyprexa Hyperglycemia, Zyprexa Schizophrenia, Zyprexa Recall Lawsuit, Zyprexa Lawsuit
